Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ProShares UltraShort Nasdaq Biotechnology BIS

The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.


NDAQ:BIS - Post by User

Comment by mdaffinon Sep 29, 2015 3:34pm
207 Views
Post# 24146384

RE:RE:Looks like biotech short is in major play

RE:RE:Looks like biotech short is in major playWow - sentiment has really changed. LABD has doubled in a week and BIS is up 50 % since I started trading this (mainly badly, so don't think I made a lot). LABD/U stocks are all the non money making biotech, while BIS/BIB has some moneymaking (but its biotech, so mainly money loosing). These ETF's are also useful for determining overall market direction.

I think LABD could hit 90 and BIS 60, but who knows if it can go higher.
<< Previous
Bullboard Posts